Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $80.50 $93.35 Friday, 10th May 2024 BMRN stock ended at $81.03. This is 0.84% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 1.50% from a day low at $80.74 to a day high of $81.95.
90 days $80.50 $94.15
52 weeks $76.02 $99.55

Historical BioMarin Pharmaceutical Inc. prices

Date Open High Low Close Volume
Sep 16, 2016 $94.82 $97.22 $94.02 $96.86 2 249 300
Sep 15, 2016 $95.23 $96.94 $94.01 $95.38 1 014 300
Sep 14, 2016 $94.50 $96.74 $93.79 $95.30 1 253 300
Sep 13, 2016 $95.60 $95.72 $92.85 $93.88 1 205 800
Sep 12, 2016 $93.33 $96.53 $93.00 $96.24 1 082 900
Sep 09, 2016 $96.21 $97.50 $94.02 $94.03 1 241 200
Sep 08, 2016 $96.08 $98.22 $95.04 $97.44 1 177 200
Sep 07, 2016 $94.95 $96.23 $93.60 $96.14 1 473 500
Sep 06, 2016 $95.96 $97.65 $94.92 $95.59 1 072 500
Sep 02, 2016 $95.30 $96.49 $93.86 $95.73 801 800
Sep 01, 2016 $93.70 $95.49 $92.79 $95.19 1 008 200
Aug 31, 2016 $95.29 $95.95 $93.02 $93.89 1 264 600
Aug 30, 2016 $95.75 $96.61 $94.84 $94.95 710 300
Aug 29, 2016 $96.26 $96.79 $94.88 $95.74 796 300
Aug 26, 2016 $95.09 $96.36 $94.42 $96.22 1 287 700
Aug 25, 2016 $95.75 $96.97 $92.35 $94.97 1 629 700
Aug 24, 2016 $99.22 $102.06 $94.50 $95.13 2 472 900
Aug 23, 2016 $99.11 $99.95 $97.44 $99.43 1 691 000
Aug 22, 2016 $95.67 $98.50 $95.18 $98.17 3 976 800
Aug 19, 2016 $93.07 $93.40 $91.76 $91.99 698 600
Aug 18, 2016 $92.85 $93.88 $92.02 $93.52 963 900
Aug 17, 2016 $92.14 $94.06 $91.00 $93.30 1 496 600
Aug 16, 2016 $92.75 $93.23 $90.91 $91.74 1 477 400
Aug 15, 2016 $92.90 $94.22 $92.30 $93.11 1 833 200
Aug 12, 2016 $91.49 $92.49 $91.02 $92.44 1 338 400
Click to get the best stock tips daily for free!

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical. BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form o... BMRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT